Table II.
Association between BML volume (total, subchondral & ligament-based) and symptoms
MRI parameter | Outcome |
|||
---|---|---|---|---|
b (95% CI), P value |
||||
WOMAC† pain score | WOMAC stiffness score | WOMAC function score | WOMAC total score | |
Total BML volume‡,* (N = 45) | 0.3 (−0.3 to 0.9), 0.26 | 0.2 (−0.5 to 0.9), 0.63 | 0.5 (−0.1 to 1.2), 0.11 | 0.5 (−0.1 to 1.0), 0.13 |
Total subchondral BML volume‡,* (N = 45) | 0.3 (−0.3 to 1.0), 0.31 | 0.2 (−0.6 to 1.0), 0.64 | 0.5 (−0.2 to 1.2), 0.15 | 0.5 (−0.2 to 1.1), 0.16 |
Total ligament-based BML volume‡,* (N = 19) | 1.9 (−1.6 to 5.3), 0.29 | 0.2 (−3.9 to 4.3), 0.93 | 2.8 (−1.0 to 6.5), 0.15 | 2.4 (−1.0 to 5.8), 0.17 |
All results presented with 95% confidence intervals (CI).
N-values correspond to the number of participants included in each analyses.
Volumes include cyst-like component volume.
WOMAC index; range from 0 to 100 units with higher scores denoting worse pain and disability.
Beta coefficients are scaled to reflect a unit change in WOMAC score (0–100) for a 1 cm3 increase in volume in the structural parameter.